Amniocentesis in Nicosia, Cyprus
Amniocentesis is a specialist diagnostic procedure that provides a definitive chromosomal or genetic diagnosis during the second trimester of pregnancy. At Veronika Stavrou Fetal Medicine Consultant in Nicosia, Amniocentesis is performed personally by Dr. Veronika Stavrou, a Fetal Medicine Consultant with extensive experience in invasive prenatal diagnostic procedures.
What is Amniocentesis?
Amniocentesis is an invasive diagnostic procedure in which a small sample of amniotic fluid — the fluid surrounding the baby in the womb — is withdrawn for laboratory analysis. Amniotic fluid contains fetal cells that carry the baby's genetic material, enabling a definitive chromosomal and genetic diagnosis.
Amniocentesis is typically offered when screening results indicate an elevated risk of a chromosomal condition, when there is a known family history of a genetic disorder that can be tested prenatally, or when other ultrasound findings require further investigation.
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Other chromosomal abnormalities
Specific genetic conditions where a known familial mutation is present
Certain infections affecting the baby
When is Amniocentesis performed?
Amniocentesis is typically performed from 15 weeks of pregnancy onwards. It is the most widely used invasive prenatal diagnostic test in the second trimester. For women who receive a high-risk screening result after the first trimester window for CVS has passed, Amniocentesis is the recommended diagnostic option.
What does the procedure involve?
Amniocentesis at Veronika Stavrou Fetal Medicine Consultant is performed under continuous ultrasound guidance by Dr. Veronika Stavrou. A fine needle is passed through the abdomen and into the amniotic sac. A small sample of amniotic fluid (approximately 15–20ml) is withdrawn. The procedure typically takes 10–15 minutes and is carried out as an outpatient appointment.
Rest is recommended for 24–48 hours following Amniocentesis.
Contact the clinic immediately if you experience heavy bleeding, fever, significant pain, or leakage of fluid.
What are the risks of Amniocentesis?
Amniocentesis carries a small risk of miscarriage. The procedure-related miscarriage rate is approximately 0.5%, though this varies with individual circumstances. Dr. Stavrou's extensive experience in invasive prenatal procedures — including experience gained in specialist fetal medicine centres abroad — means that the procedure is performed with the highest standard of care and technique.
Dr. Stavrou will discuss the benefits, risks, and alternatives with you in full before the procedure. The decision to proceed is always yours.
Amniocentesis is used to obtain a definitive diagnosis of chromosomal conditions or genetic disorders in the developing baby. It is most commonly performed when a screening test — such as the NT scan, combined first trimester screening, or NIPT — has returned a high-risk result, or when there is a known familial genetic condition that can be tested for prenatally.
Most women find Amniocentesis uncomfortable rather than painful. The sensation is often described as pressure or mild cramping. Dr. Stavrou will ensure you are fully informed and as comfortable as possible throughout the procedure.
Both procedures provide definitive chromosomal diagnoses, but they differ in timing and the sample used. CVS is performed in the first trimester (11– 13 weeks + 6 days) using placental tissue. Amniocentesis is performed from 15 weeks using amniotic fluid. Both carry a small procedural risk of miscarriage. The most appropriate procedure depends on gestational age and clinical circumstances.